カテゴリ： MarketLine, アメリカ, 企業調査

United Therapeutics Corporation：企業の戦略・SWOT・財務情報

◆英語タイトル：United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4467
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：44
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

United Therapeutics Corporation – Strategy, SWOT and Corporate Finance Report
Summary

United Therapeutics Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

United Therapeutics Corporation (United Therapeutics or ‘the company’) is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life threatening conditions. The product portfolio of the company includes Remodulin Injection; Tyvaso (treprostinil) Inhalation Solution; Adcirca (tadalafil) Tablets; Orenitram (treprostinil) extended release tablets; PLX Cells; Replacement Lungs- Transplantation and Self-Injectable Prostacyclin Analogues- PAH. United Therapeutics sells its products through specialty pharmaceutical distributors in the US. The company operates in Europe, Israel and the Middle East, Asia and South and Central America. United Therapeutics is headquartered in Silver Spring, Maryland, the US.

Scope

- Detailed information on United Therapeutics Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting United Therapeutics Corporation in the form of a SWOT analysis
- An in-depth view of the business model of United Therapeutics Corporation including a breakdown and examination of key business segments
- Intelligence on United Therapeutics Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about United Therapeutics Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of United Therapeutics Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess United Therapeutics Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on United Therapeutics Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
United Therapeutics Corporation: Company Overview 9
United Therapeutics Corporation: Overview and Key Facts 9
United Therapeutics Corporation: Overview 9
United Therapeutics Corporation: Key Facts 9
United Therapeutics Corporation: Key Employees 10
United Therapeutics Corporation: Key Employee Biographies 11
United Therapeutics Corporation: Major Products and Services 12
United Therapeutics Corporation: Company History 13
United Therapeutics Corporation: Management Statement 16
United Therapeutics Corporation: Locations and Subsidiaries 19
United Therapeutics Corporation: Key Competitors 20
United Therapeutics Corporation: Company Analysis 21
United Therapeutics Corporation: Business Description 21
United Therapeutics Corporation: SWOT Analysis 23
United Therapeutics Corporation: SWOT Overview 23
United Therapeutics Corporation: Strengths 23
United Therapeutics Corporation: Weaknesses 24
United Therapeutics Corporation: Opportunities 24
United Therapeutics Corporation: Threats 25
United Therapeutics Corporation: Corporate Financial Deals Activity 27
United Therapeutics Corporation: Financial Deals Overview 27
United Therapeutics Corporation: Targets and Partners 29
United Therapeutics Corporation: Top Deals 2014 – 2018YTD* 30
United Therapeutics Corporation: Advisors 31
United Therapeutics Corporation: Top Legal Advisors 31
United Therapeutics Corporation: Mergers and Acquisitions 32
United Therapeutics Corporation: Corporate Venturing 33
United Therapeutics Corporation: Partnership 34
United Therapeutics Corporation: Recent Developments 35
United Therapeutics Corporation: News and Events Summary 35
United Therapeutics Corporation: Corporate Governance 37
United Therapeutics Corporation: Financial Deals 38
United Therapeutics Corporation: Financial Performance 38
United Therapeutics Corporation: Grants 40
United Therapeutics Corporation: Market Developments 40
United Therapeutics Corporation: Regulatory and Legal Events 41
United Therapeutics Corporation: Research & Development 41
Appendix 42
Contact Us 42
Methodology 42
About MarketLine 43

List of Tables
Table 1: United Therapeutics Corporation: Key Facts
Table 2: United Therapeutics Corporation: Key Employees
Table 3: United Therapeutics Corporation: Locations and Subsidiaries
Table 4: United Therapeutics Corporation: Key Competitors
Table 5: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: United Therapeutics Corporation: M&A Activity by Geography (TTM*)
Table 7: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
Table 9: United Therapeutics Corporation: Targets and Partners
Table 10: United Therapeutics Corporation: Top Deals 2014 - 2018YTD*
Table 11: United Therapeutics Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: United Therapeutics Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: United Therapeutics Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 14: United Therapeutics Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: United Therapeutics Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: United Therapeutics Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: United Therapeutics Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: United Therapeutics Corporation: News and Events Summary
Table 19: United Therapeutics Corporation: Corporate Governance
Table 20: United Therapeutics Corporation: Financial Deals
Table 21: United Therapeutics Corporation: Financial Performance
Table 22: United Therapeutics Corporation: Grants
Table 23: United Therapeutics Corporation: Market Developments
Table 24: United Therapeutics Corporation: Regulatory and Legal Events
Table 25: United Therapeutics Corporation: Research & Development

List of Figures
Figure 1: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: United Therapeutics Corporation: M&A Activity by Geography (TTM*)
Figure 3: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
Figure 5: United Therapeutics Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: United Therapeutics Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: United Therapeutics Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: United Therapeutics Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: United Therapeutics Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: United Therapeutics Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[United Therapeutics Corporation：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • JACCS Co Ltd：企業の戦略・SWOT・財務分析
    JACCS Co Ltd - Strategy, SWOT and Corporate Finance Report Summary JACCS Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • BioVectra Inc-製薬・医療分野：企業M&A・提携分析
    Summary BioVectra Inc (BioVectra), a subsidiary of Mallinckrodt Plc is a manufacturer and marketer of pharmaceutical ingredients. The company’s products include reducing reagents, bioprocessing reagents, molecular biology reagents, clinical diagnostic raw materials, high molecular weight vectra MPEG …
  • Innoviva Inc (INVA)：企業の財務・戦略的SWOT分析
    Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Northrop Grumman Technical Services Inc.：企業の戦略・SWOT・財務分析
    Northrop Grumman Technical Services Inc. - Strategy, SWOT and Corporate Finance Report Summary Northrop Grumman Technical Services Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Cerus Corp (CERS)-医療機器分野：企業M&A・提携分析
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Enzymatica AB (ENZY)：企業の財務・戦略的SWOT分析
    Summary Enzymatica AB (Enzymatica) is a life science company that develops and markets medical products for various virus and bacterial infections. The company offers mouth sprays and veterinary products. Its veterinary products comprise dental health and skin relief enzyme based gels, dental and de …
  • Cesca Therapeutics Inc (KOOL)：製品パイプライン分析
    Summary Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its device di …
  • Amey Plc：企業の戦略的SWOT分析
    Amey Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Gol Linhas Aereas Inteligentes SA ：企業の戦略・SWOT・財務情報
    Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report Summary Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Fabric Genomics Inc-製薬・医療分野：企業M&A・提携分析
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc is a healthcare solutions provider that offers genome analysis services. The company provides solutions for researchers and clinicians to analyze genomes and disease-causing variants and genes. Its products include opal software and standalon …
  • Nacco Industries Inc：企業の戦略・SWOT・財務情報
    Nacco Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Nacco Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Petrolina (Holdings) Public Ltd (PHL)：企業の財務・戦略的SWOT分析
    Petrolina (Holdings) Public Ltd (PHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Suzuki Motor Corp (7269)：企業の財務・戦略的SWOT分析
    Suzuki Motor Corp (7269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Allenex AB：製薬・医療：M&Aディール及び事業提携情報
    Summary Allenex AB (Allenex), formerly LinkMed AB, a subsidiary of CareDx Inc, is a blood stemcells and organs transplantation service provider. The company offers olerup SSP and absorber. Its oleruu is used before the transplantation. Allenex offers pre transplantation, transplantation and post tra …
  • Vodacom Group Limited：企業の戦略・SWOT・財務情報
    Vodacom Group Limited - Strategy, SWOT and Corporate Finance Report Summary Vodacom Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hubbell Incorporated：企業の戦略・SWOT・財務情報
    Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report Summary Hubbell Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Pinnacle Investment Management Group Limited (PNI)：企業の財務・戦略的SWOT分析
    Pinnacle Investment Management Group Limited (PNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Strayer Education Inc (STRA)：企業の財務・戦略的SWOT分析
    Summary Strayer Education Inc (Strayer) operates as an educational service provider that offers undergraduate and graduate degree programs. The institute’s degree programs include business administration, accounting, information technology, education, health services administration and public admini …
  • Maerki Baumann & Co. AG：企業の戦略・SWOT・財務情報
    Maerki Baumann & Co. AG - Strategy, SWOT and Corporate Finance Report Summary Maerki Baumann & Co. AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • JSFC Sistema (AFKS)：石油・ガス：M&Aディール及び事業提携情報
    Summary JSFC Sistema (Sistema) is a diversified holding company which offers a wide range of consumer services in Russia and the Commonwealth of Independent States (CIS).The company undertakes businesses in various sectors, including telecommunications, high technology, real estate development, reta …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆